3.100USD-7.19%Mkt Cap: 217.10M USDP/E: —Last update: 2026-06-01
YD Bio Limited a biopharmaceutical company focuses on blood-based cancer detection and develops stem cell- and exosome-based therapeutics to transform the treatment of spectrum of diseases with unmet medical needs. The c…
Industry Peers
BiotechnologyIndicators:|
Key Statistics
Company
Market Cap217.10M USD
Enterprise Value1.53M USD
Revenue (TTM)510.36K USD
Gross Profit167.41K USD
Net Income (TTM)-8.31M USD
Revenue/Share0.4660 USD
Last Price3.100 USD
Fiscal Year EndDec 2024
MR QuarterDec 2024
Employees—
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA-1.13
EV/Revenue3.00
P/S446.89
P/B0.70
EPS (TTM)-0.12
EPS (Forward)—
52W Range
3.0000% of range25.00
52W High25.00 USD
52W Low3.000 USD
Profitability
Gross Margin28.05%
Oper. Margin-444.59%
EBITDA Margin-265.93%
Profit Margin-1392.61%
ROE291.05%
ROA-60.32%
Growth
Revenue Growth95.60%
Earnings Growth—
Cash Flow & Leverage
Operating CF-6.60M USD
CapEx (TTM)1.44M USD
FCF Margin-759.38%
FCF Yield-1.79%
Net Debt-3.11M USD
Net Debt/EBITDA2.29
Balance Sheet
Debt/Equity-0.00
Current Ratio13.18
Quick Ratio12.91
Book Value/Sh4.571 USD
Cash/Share2.173 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.70.83M
Float319.87K
Insiders81.01%
Institutions0.49%
Short Interest
Short Ratio1.0d
Short % Float0.10%
Short % Out.0.02%
Shares Short15.77K
Short (prev mo.)22.93K
Technical
SMA 505.627 (-44.9%)
SMA 20010.91 (-71.6%)
Beta-0.06
S&P 52W Chg27.70%
Avg Vol (30d)10.58K
Avg Vol (10d)9.53K
Technical Indicators
RSI (14)21.2
MACD-0.5195
MACD Signal-0.4076
MACD Hist.-0.1119
BB Upper5.936 USD
BB Middle4.796 USD
BB Lower3.656 USD
BB Width47.55%
ATR (14)0.4195 USD
Vol Ratio (20d)1.83x